Drug/Small Molecule:
fentanyl

2D structure

Overview

Generic Names: Fentanila [INN-Spanish]; Fentanyl citrate; Fentanylum [INN-Latin]; fentanyl
Trade Names: Actiq; Duragesic; Duragesic-100; Durogesic; Fentanest; Fentanil; Nasalfent; Pentanyl; Phentanyl; Rapinyl; Sentonil; Sublimaze
Brand Mixtures: Innovar Injection (droperidol + fentanyl citrate)
PharmGKB Accession Id: PA449599

Description

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) (source: Drug Bank)

Indication

For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy. (source: Drug Bank)

ATC Therapeutic Categories

  • N01AH:Opioid anesthetics
  • N02AB:Phenylpiperidine derivatives

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Fentanyl's analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. (source: Drug Bank)

Pharmacology

Fentanyl is an opioid analgesic. Fentanyl interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, Fentanyl exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Fentanyl may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Fentanyl depresses the respiratory centers, depresses the cough reflex, and constricts the pupils. (source: Drug Bank)

Food Interactions

Avoid alcohol. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Fentanyl is metabolized primarily via human cytochrome P450 3A4 isoenzyme system. (source: Drug Bank)

Protein Binding

80-85% (source: Drug Bank)

Absorption

Bioavailability is 92% following transdermal administration and 50% following buccal administration. (source: Drug Bank)

Toxicity

Fentanyl has an LD50 of 3.1 milligrams per kilogram in rats, and, 0.03 milligrams per kilogram in monkeys. The LD50 in humans is not known. (source: Drug Bank)

Isomeric SMILES Code:

CCC(=O)N(c1ccccc1)C2CCN(CC2)CCc3ccccc3 (source: Drug Bank)

The following genes are in curated knowledge about this drug.

  Gene Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Has annotations
ABCB1
  •   
  • PD
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
CYP3A
  •   
  •   
  • PK
  •   
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Has annotations
CYP3A4
  •   
  •   
  • PK
  •   
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Has annotations
CYP3A5
  •   
  •   
  • PK
  •   
  •   
Publications

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
OPRD1 Uncurated Annotation (source: Drug Bank)
OPRM1 Uncurated Annotation (source: Drug Bank)

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
amiodarone Uncurated Annotation Possible bradycardia, hypotension (source: Drug Bank)
amprenavir Uncurated Annotation The protease inhibitor increases the effect and toxicity of fentanyl (source: Drug Bank)
cimetidine Uncurated Annotation Cimetidine increases the effect of the narcotic (source: Drug Bank)
fluconazole Uncurated Annotation The imidazole increases levels/toxicity of fentanyl (source: Drug Bank)
fosamprenavir Uncurated Annotation The protease inhibitor increases the effect and toxicity of fentanyl (source: Drug Bank)
indinavir Uncurated Annotation The protease inhibitor increases the effect and toxicity of fentanyl (source: Drug Bank)
itraconazole Uncurated Annotation The imidazole increases levels/toxicity of fentanyl (source: Drug Bank)
ketoconazole Uncurated Annotation The imidazole increases levels/toxicity of fentanyl (source: Drug Bank)
naltrexone Uncurated Annotation Naltrexone may precipitate a withdrawal syndrome in opioid-dependent individuals (source: Drug Bank)
nelfinavir Uncurated Annotation The protease inhibitor increases the effect and toxicity of fentanyl (source: Drug Bank)
rifampin Uncurated Annotation Rifampin reduces levels and efficacy of fentanyl/alfentanyl (source: Drug Bank)
ritonavir Uncurated Annotation Ritonavir increases the effect and toxicity of fentanyl/alfentanyl (source: Drug Bank)
saquinavir Uncurated Annotation The protease inhibitor increases the effect and toxicity of fentanyl (source: Drug Bank)
voriconazole Uncurated Annotation The imidazole increases levels/toxicity of fentanyl (source: Drug Bank)

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. Physicochemical determinants of human renal clearance

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00813
KEGG Drug ID:
D00320
PubChem Compound ID:
3345
PubChem Substance ID:
153132
IUPHAR Ligand ID:
1626

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.